Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Adiposity / Obesity & Trimethylamine-N-Oxide (TMAO)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Studies on adiposity / obesity, diabetes, Hepatic disease / Liver disease, chronic kidney disease, and cognitive disorders indicate that Trimethylamine-N-Oxide (TMAO) effects are unique in pathologic conditions compared to healthy controls
Krueger et al. 2021 Nutrients 13: 2873

Urinary Trimethylamine-N-Oxide (TMAO) levels have been associated with choline consumption and chronic disease
Tarr 1941 J. Fish. Re…

Evaluation of an 8-Week Vegan Diet on Plasma Trimethylamine-N-Oxide and Postchallenge Glucose in Adults with Dysglycemia or Obesity
Argyridou et al. 2021 J Nutr 151: 1844-1853
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang et al. 2011
The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It’s Not All Bad
Krueger et al. 2021 Nutrients 13: 2873
Review
The fate of trimethylamine oxide and trimethylamine in man
Tarr 1941 J. Fish. Res. Board Can. 5b: 211-216
Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary diseases
de la Huerga & Popper 1951 J. Clin. Investig. 30: 463-470

7/1/2026